- Home
- EVTV vs APVO Comparison
EVTV vs APVO Comparison
Compare EVTV & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- APVO
- Stock Information
- Founded
- EVTV 2012
- APVO 2016
- Country
- EVTV United States
- APVO United States
- Employees
- EVTV N/A
- APVO N/A
- Industry
- EVTV Auto Manufacturing
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- APVO Health Care
- Exchange
- EVTV Nasdaq
- APVO Nasdaq
- Market Cap
- EVTV 5.4M
- APVO 5.4M
- IPO Year
- EVTV 2017
- APVO N/A
- Fundamental
- Price
- EVTV $0.25
- APVO $1.38
- Analyst Decision
- EVTV
- APVO Strong Buy
- Analyst Count
- EVTV 0
- APVO 1
- Target Price
- EVTV N/A
- APVO $296.00
- AVG Volume (30 Days)
- EVTV 510.2K
- APVO 1.2M
- Earning Date
- EVTV 05-19-2025
- APVO 05-07-2025
- Dividend Yield
- EVTV N/A
- APVO N/A
- EPS Growth
- EVTV N/A
- APVO N/A
- EPS
- EVTV N/A
- APVO N/A
- Revenue
- EVTV $1,730,010.00
- APVO N/A
- Revenue This Year
- EVTV N/A
- APVO N/A
- Revenue Next Year
- EVTV N/A
- APVO N/A
- P/E Ratio
- EVTV N/A
- APVO N/A
- Revenue Growth
- EVTV N/A
- APVO N/A
- 52 Week Low
- EVTV $0.23
- APVO $0.94
- 52 Week High
- EVTV $2.99
- APVO $180.19
- Technical
- Relative Strength Index (RSI)
- EVTV 34.47
- APVO 31.11
- Support Level
- EVTV $0.23
- APVO $0.94
- Resistance Level
- EVTV $0.26
- APVO $2.64
- Average True Range (ATR)
- EVTV 0.02
- APVO 0.45
- MACD
- EVTV 0.01
- APVO -0.07
- Stochastic Oscillator
- EVTV 50.56
- APVO 16.42
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.